Evidence map›Paper›PMID 29355439›Full record

ArticleDiabetes technology & therapeutics2018

Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia.

Alejandro J Laguna Sanz, Christopher M Mulla, Kristen M Fowler, Emilie Cloutier, Allison B Goldfine, Brett Newswanger, Martin Cummins, Sunil Deshpande, Steven J Prestrelski, Poul Strange and 4 more

Abstract read
In one paragraph

Article in Diabetes technology & therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Modeling Meal Absorption in Subjects Post-Roux-en-Y Gastric Bypass Surgery Leading to Post-Bariatric Hypoglycemia.Control Technology and Applications. Control Technology and Applications · 2025
    Article
  5. Article
  6. Tailoring Exercise Prescription for Effective Diabetes Glucose Management.The Journal of clinical endocrinology and metabolism · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies.The Journal of clinical endocrinology and metabolism · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Alejandro J Laguna Sanz1 Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University , Cambridge, Massachusetts.
Christopher M Mulla2 Research Division, Joslin Diabetes Center , Boston, Massachusetts.
Kristen M Fowler2 Research Division, Joslin Diabetes Center , Boston, Massachusetts.
Emilie Cloutier2 Research Division, Joslin Diabetes Center , Boston, Massachusetts.
Allison B Goldfine2 Research Division, Joslin Diabetes Center , Boston, Massachusetts.
Brett Newswanger3 Research and Development Xeris Pharmaceuticals, Inc. , Austin, Texas.
Martin Cummins3 Research and Development Xeris Pharmaceuticals, Inc. , Austin, Texas.
Sunil Deshpande1 Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University , Cambridge, Massachusetts.
Steven J Prestrelski3 Research and Development Xeris Pharmaceuticals, Inc. , Austin, Texas.
Poul Strange3 Research and Development Xeris Pharmaceuticals, Inc. , Austin, Texas.
Howard Zisser4 Department of Chemical Engineering, University of California , Santa Barbara, Santa Barbara, California.
Francis J Doyle1 Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University , Cambridge, Massachusetts.
Eyal Dassau1 Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University , Cambridge, Massachusetts.
Mary-Elizabeth Patti2 Research Division, Joslin Diabetes Center , Boston, Massachusetts.
Joslin Diabetes Center · USHarvard University · USUniversity of California, Santa Barbara · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
TRAINING IN DIABETES AND METABOLISMT32DK007260 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$13.6M
Closed-Loop Glucagon Pump for Treatment of Post-Bariatric HypoglycemiaR44DK107114 · NIDDK · XERIS PHARMACEUTICALS, INC. · PI DASSAU, EYAL, PATTI, MARY E · 2015 to 2017
$1.8M
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R44 DK107114NIDDK NIH HHS T32 DK007260
6 · The paper itself

Abstract

backgroundPostbariatric hypoglycemia (PBH) is a complication of bariatric surgery with limited therapeutic options. We developed an event-based system to predict and detect hypoglycemia based on continuous glucose monitor (CGM) data and recommend delivery of minidose liquid glucagon.

methodsWe performed an iterative development clinical study employing a novel glucagon delivery system: a Dexcom CGM connected to a Windows tablet running a hypoglycemia prediction algorithm and an Omnipod pump filled with an investigational stable liquid glucagon formulation. Meal tolerance testing was performed in seven participants with PBH and history of neuroglycopenia. Glucagon was administered when hypoglycemia was predicted. Primary outcome measures included the safety and feasibility of this system to predict and prevent severe hypoglycemia. Secondary outcomes included hypoglycemia prediction by the prediction algorithm, minimization of time below hypoglycemia threshold using glucagon, and prevention of rebound hyperglycemia.

resultsThe hypoglycemia prediction algorithm alerted for impending hypoglycemia in the postmeal state, prompting delivery of glucagon (150 μg). After observations of initial incomplete efficacy to prevent hypoglycemia in the first two participants, system modifications were implemented: addition of PBH-specific detection algorithm, increased glucagon dose (300 μg), and a second glucagon dose if needed. These modifications, together with rescue carbohydrates provided to some participants, contributed to progressive improvements in glucose time above the hypoglycemia threshold (75 mg/dL).

conclusionsPreliminary results indicate that our event-based automatic monitoring algorithm successfully predicted likely hypoglycemia. Minidose glucagon therapy was well tolerated, without prolonged or severe hypoglycemia, and without rebound hyperglycemia.

Indexed as

AdultAlgorithmsBariatric SurgeryBlood GlucoseFemaleGlucagonHumansHypoglycemiaMaleMiddle AgedPostoperative ComplicationsTreatment OutcomeBlood GlucoseGlucagonBariatric surgeryGlucagonHypoglycemia

Identifiers

PMID29355439
PMCPMC5771550
OpenAlexW2784732818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.